Appili Therapeutics Inc.
APLI.TO
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.49% | -668.41% | 142.42% | 31.28% | 52.94% |
| Total Depreciation and Amortization | -7.69% | 18.18% | -24.14% | 38.10% | -16.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -158.63% | -82.20% | 7.45% | 107.62% | -68.54% |
| Change in Net Operating Assets | -69.22% | 651.39% | 76.50% | -212.43% | 744.34% |
| Cash from Operations | -11,884.78% | -100.64% | 328.04% | -205.37% | 410.78% |
| Capital Expenditure | -- | -- | 100.00% | 58.33% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | 58.33% | -- |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -2.73% | 34.74% | -62.68% | -3.76% | 37.85% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -263.85% | 20.73% | -26.15% | 20.25% | 13.30% |
| Cash from Financing | -83.66% | 28.17% | -46.90% | 7.94% | -112.74% |
| Foreign Exchange rate Adjustments | 211.42% | -181.91% | 1,357.58% | 1,200.00% | -200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -655.63% | -110.27% | 312.19% | -228.26% | 76.57% |